KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine

.

Source: Expert Opinion on Biological Therapy - August 18, 2021 Category: Drugs & Pharmacology Authors: Dahna Coupez Pauline Hulo Yann Touchefeu Marc G Denis Jaafar Bennouna Source Type: research